Prognostic Value of Androgen Receptor Expression and Mutations Within Oncogenes and Tumor Suppressor Genes in Patients Treated for High Risk Prostate Cancer With Proton Therapy (PRX32)
WithdrawnOBSERVATIONAL
0
Timeline
Start Date
December 7, 2017
Primary Completion Date
September 30, 2020
Study Completion Date
September 30, 2020
Conditions
Prostate Cancer
Trial Locations (1)
32206
University of Florida Proton Therapy Institute, Jacksonville